Why the study?
Does endothelin receptor antagonism affect coronary resistance and ET-1 release in isolated rat hearts?
Does endothelin receptor antagonism affect coronary resistance and ET-1 release in isolated rat hearts?
Answers are grounded in this paper and cite their sources.
ET(B) receptors play a crucial role in binding and sequestering ET-1, and their blockade displaces ET-1 which then accesses ET(A) receptors to cause coronary constriction.
The effects of two endothelin (ET) receptor antagonists, PD 155080 (ET(A) selective) and BQ-788 (ET(B) selective), on cardiac function and ET-1 release were studied in isolated rat hearts. In normoxic hearts, infusion of PD 155080 (50 nM-5 microM) reduced coronary resistance, but had no effect on ET-1 release. Low concentrations of BQ-788 (2 and 20 nM) had no effect on coronary resistance; high concentrations (0.2 and 2 microM) increased it approximately 2-fold; all concentrations increased ET-1 release (up to 24-fold). Similar results were obtained in reperfused hearts. Although concentrations of ET-1 were higher in interstitial fluid than coronary effluent, levels never exceeded the low pg/ml range. These results indicate that (1) ET(A) receptors mediate coronary constriction, whereas ET(B) receptors bind and sequester ET-1, and (2) ET-1 displaced by ET(B) antagonist accesses ET(A) receptors resulting in coronary constriction.
No takes yet. Share an insight, caveat, or question.
Brünner et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: